Exchange Traded Concepts, LLC Simulations Plus, Inc. Transaction History

Exchange Traded Concepts, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 18, 2021	SELL	$38.45 - $55.66 $482,778 - $698,866	-12,556 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$49.67 - $68.96 $58,809 - $81,648	1,184 Added 10.41%	12,556 $689,000
Q1 2021 Apr 20, 2021	BUY	$60.06 - $89.52 $38,017 - $56,666	633 Added 5.89%	11,372 $719,000
Q4 2020 Jan 19, 2021	BUY	$53.26 - $77.18 $55,603 - $80,575	1,044 Added 10.77%	10,739 $772,000
Q3 2020 Oct 30, 2020	BUY	$57.51 - $75.36 $38,244 - $50,114	665 Added 7.36%	9,695 $731,000
Q2 2020 Jul 15, 2020	BUY	$32.91 - $59.82 $297,177 - $540,174	9,030 New	9,030 $540,000

172

15.7M

11.1K

7.3K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $588M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.